IOCL Q3 FY25-26 Results: Profitability Obscured Amidst High Debt and Aggressive Capex
The Numbers: A Performance Puzzle
Indian Oil Corporation Limited (IOCL) has unveiled its unaudited financial results for the third quarter and nine months ended December 31, 2025. However, a significant void exists in the investor handout: crucial profitability figures such as Profit After Tax (PAT), Profit Before Tax (PBT), and Revenue for these periods are conspicuously absent, severely hampering a quantitative assessment of the company's financial performance.
The Financial Deep Dive: Debt and Expenditure
What is explicitly reported is a substantial Debt Level of ₹115,948 Cr as of December 31, 2025. Interest Expenditure for Q3 FY25-26 stood at ₹198 Cr, accumulating to ₹6120 Cr for the nine-month period. Conversely, Interest Income was ₹439 Cr for Q3 and ₹1346 Cr for the nine months. The company also noted impacts from Exchange Fluctuations, with Crude Liability at (₹297) Cr for Q3 and (₹1032) Cr for 9M, and Other than Crude Liability impacts at (₹460) Cr for Q3 and (₹1926) Cr for 9M.
Operational Performance: Throughput Metrics
Operationally, IOCL reported refinery throughput of 19.4 MMT in Q3 FY25-26, operating at 109.7% capacity utilization. For the nine months, throughput reached 77.9 MMT at 76.3% utilization. Marketing operations data was provided in volume terms, but revenue specifics are not detailed.
Massive Capex Program Underway
The company is driving forward with an ambitious capital expenditure program. Key projects include the Panipat Refinery Expansion (91.6% physical progress, completion expected Dec'2026), Gujarat Refinery Expansion (85.8% progress, Jul'25 completion), and the Barauni Refinery Expansion (89.4% progress, Aug'2026). Other significant undertakings involve the PX-PTA Complex at Paradip, a New Mundra Panipat Crude Oil Pipeline, a New R&D Campus-II, and a Poly Butadiene Rubber Plant.
Capex incurred during 9M FY25-26 totals ₹12261 Cr in Refineries, ₹1345 Cr in Pipelines, ₹1374 Cr in Marketing, ₹2183 Cr in Petchem, and ₹223 Cr in E&P. The total Capex Target for FY2025-26 is ₹24336 Cr, with an additional ₹34701 Cr invested in JVs/Subsidiaries.
Risks & Outlook: Navigating Opacity
The primary risk for investors is the lack of clarity on profitability and revenue, making it difficult to gauge the actual financial performance and efficiency of operations. The substantial debt burden of over ₹1.15 lakh crore adds further financial strain, especially with ongoing interest expenditures. While the extensive capital expenditure signals a commitment to future growth and expansion, the absence of forward-looking guidance or management commentary from concalls leaves the market speculating on the strategic implications and the timeline for returns on these massive investments.
